Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has provided an update.
Shanghai MicroPort MedBot received CSRC approval to convert 5,989,798 previously unlisted shares held by two shareholders into H shares, representing about 0.58% of its total share capital, paving the way for trading on the Hong Kong Main Board pending Stock Exchange procedures. The move advances the company’s H share full circulation plan, signaling a broader shareholder base and enhanced liquidity once remaining regulatory steps are met, though investors are advised caution until completion.
The most recent analyst rating on (HK:2252) stock is a Hold with a HK$31.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a China-based medical robotics company specializing in surgical robot R&D and commercialization, focused on expanding its presence in the Hong Kong capital market through H-share listings.
Average Trading Volume: 6,111,022
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.81B
For detailed information about 2252 stock, go to TipRanks’ Stock Analysis page.